OrbiMed Advisors’ team includes 16 investment professionals. The average tenure for the Firm’s senior team is 17 years.
Sign-up to view OrbiMed Advisors’ full profile and discover more large private equity firm investors just like it.
601 Lexington Avenue, 54th Floor,
New York,
New York
10022
United States
(212) 739-6400
www.orbimed.com
info@orbimed.com
| Name | Title | Phone | Office | |
|---|---|---|---|---|
 |
Founding General Partner & Managing Partner | New York | ||
|
Carl is a Managing Partner and leads OrbiMed’s private equity team. Carl joined OrbiMed’s predecessor firm in 1995 and was a founding General Partner of OrbiMed in 1998. He did his undergraduate work at Harvard (A.B., Chemistry & Physics, 1987), worked at the biotechnology company Imclone Systems (1987-1988), then attained a Ph.D. in Biology from MIT (1993), and was a Postdoctoral Fellow at the Rockefeller University (1993-1995). Carl has been fortunate to have been on the Forbes Midas list of top venture capital investors multiple times. He has founded and invested in numerous biotechnology companies and served on many public and private company boards. When considering investments, Carl looks for innovative technology and creative management teams and believes the key to success is a combination of integrity, hard work, and passion. |
||||
| Function: Investment | ||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
